Red Meat Intake, Doneness, Polymorphisms in Genes that Encode Carcinogen-Metabolizing Enzymes, and Colorectal Cancer Risk
- 1 November 2008
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 17 (11) , 3098-3107
Abstract
Colorectal cancer literature regarding the interaction between polymorphisms in carcinogen-metabolizing enzymes and red meat intake/doneness is inconsistent. A case-control study was conducted to evaluate the interaction between red meat consumption, doneness, and polymorphisms in carcinogen-metabolizing enzymes. Colorectal cancer cases diagnosed 1997 to 2000, ages 20 to 74 years, were identified through the population-based Ontario Cancer Registry and recruited by the Ontario Family Colorectal Cancer Registry. Controls were sex-matched and age group-matched random sample of Ontario population. Epidemiologic and food questionnaires were completed by 1,095 cases and 1,890 controls; blood was provided by 842 and 1,251, respectively. Multivariate logistic regression was used to obtain adjusted odds ratio (OR) estimates. Increased red meat intake was associated with increased colorectal cancer risk [OR (>5 versus ≤2 servings/wk), 1.67 (1.36-2.05)]. Colorectal cancer risk also increased significantly with well-done meat intake [OR (>2 servings/wk well-done versus ≤2 servings/wk rare-regular), 1.57 (1.27-1.93)]. We evaluated interactions between genetic variants in 15 enzymes involved in the metabolism of carcinogens in overcooked meat (cytochrome P450, glutathione S-transferase, UDP-glucuronosyltransferases, SULT, NAT, mEH, and AHR). CYP2C9 and NAT2 variants were associated with colorectal cancer risk. Red meat intake was associated with increased colorectal cancer risk regardless of genotypes; however, CYP1B1 combined variant and SULT1A1-638G>A variant significantly modified the association between red meat doneness intake and colorectal cancer risk. In conclusion, well-done red meat intake was associated with an increased risk of colorectal cancer regardless of carcinogen-metabolizing genotype, although our data suggest that persons with CYP1B1 and SULT1A1 variants had the highest colorectal cancer risk. (Cancer Epidemiol Biomarkers Prev 2008;17(11):3098–107)Keywords
This publication has 66 references indexed in Scilit:
- Meat consumption and risk of colorectal cancer: A meta‐analysis of prospective studiesInternational Journal of Cancer, 2006
- SULT1A1 genotype and susceptibility to colorectal cancerInternational Journal of Cancer, 2006
- RESPONSE: Re: Meat, Fish, and Colorectal Cancer Risk: The European Prospective Investigation into Cancer and NutritionJNCI: Journal of the National Cancer Institute, 2005
- Colorectal Screening is Associated with Reduced Colorectal Cancer Risk: A Case–Control Study within the Population-Based Ontario Familial Colorectal Cancer RegistryCancer Causes & Control, 2005
- Meat, Fish, and Colorectal Cancer Risk: The European Prospective Investigation into Cancer and NutritionJNCI: Journal of the National Cancer Institute, 2005
- Red meat consumption and risk of cancers of the proximal colon, distal colon and rectum: The Swedish Mammography CohortInternational Journal of Cancer, 2004
- Vegetable, fruit and meat consumption and potential risk modifying genes in relation to colorectal cancerInternational Journal of Cancer, 2004
- GENETIC EPIDEMIOLOGY OF ENVIRONMENTAL TOXICITY AND CANCER SUSCEPTIBILITY: HUMAN ALLELIC POLYMORPHISMS IN DRUG-METABOLIZING ENZYME GENES, THEIR FUNCTIONAL IMPORTANCE, AND NOMENCLATURE ISSUESDrug Metabolism Reviews, 1999
- Stage of colon cancer at diagnosis: implications for risk factor associations?International Journal of Epidemiology, 1998
- The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC)Diseases of the Colon & Rectum, 1991